NCT02531971View on ClinicalTrials.gov

Fentanyl Patch Pharmacokinetics in Healthy Adults

PHASE4CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

January 14, 2016

Primary Completion Date

October 16, 2018

Study Completion Date

October 16, 2018

Conditions
Peer Review, Research
Interventions
DRUG

Intravenous fentanyl citrate

100 micrograms (2 millilitres) via intravenous injection

DRUG

Duragesic®

TDDS dosage is 25 micrograms/hour (worn for 72 h)

DRUG

Mylan generic fentanyl

TDDS dosage is 25 micrograms/hour (worn for 72 h)

Trial Locations (1)

21201

General Clinical Research Center, Baltimore

All Listed Sponsors
collaborator

Food and Drug Administration (FDA)

FED

lead

University of Maryland, Baltimore

OTHER

NCT02531971 - Fentanyl Patch Pharmacokinetics in Healthy Adults | Biotech Hunter | Biotech Hunter